Clinical Trials and New Techniques Advance the Bladder Cancer Treatment Landscape
For Bladder Cancer Awareness Month, Jahan Aghalar, MD, discussed the latest advancements in treating patients with bladder cancer along with which targets have helped to push the field forward.
New Technologies, Holistic Treatment Approaches for Brain Cancer Emerging
For Brain Cancer Awareness Month, Charles Redfern, MD, discussed the biggest technological changes to treatment for adult patients with brain cancer and how holistic treatment remains important for treating this challenging disease.
Domvanalimb Combinations Show Clinically Meaningful Efficacy in NSCLC
Clinically meaningful differentiation across efficacy measures were seen in patients administered domvanalimb in combination with zimberleimab or etrumadenant vs zimberelimab monotherapy.
Pembrolizumab Extends EFS in Early Triple-Negative Breast Cancer
In an interview with Targeted Oncology, Lee Schwartzberg, MD, further discusses the findings of KEYNOTE-522 and pembrolizumab in patients with triple negative breast cancer.
Tennessee Oncology Achieves High Quality Score and Saves Millions During the Final Year of Medicare’s OCM
The community oncology organization, Tennessee Oncology, reportedly saved Medicare $5 million between 2019 and 2020.
Gettysburg Cancer Center Expands Clinical Trial Resources With Help of OneOncology
In an interview with Targeted Oncology™, Statish Shah, MD, the medical director of Gettysburg Cancer Center, discusses the OneOncology partnership in more detail and how it will benefit patients.
Gettysburg Cancer Center to Join the OneOncology Platform
Gettysburg Cancer Center, with clinics in Gettysburg and Hanover, PA, will join OneOncology, the national platform for independent community oncology practices, OneOncology announced.
OneOncology Announces 23 Presentations for Upcoming ASCO Meeting
The Center for Cancer and Blood Disorders to Vaccinate Patients and Caregivers
The Center for Cancer and Blood Disorders, which serves 12,000 patients a year in North Texas, is now offering their patients and caregivers the COVID-19 vaccine.
Examining the Impact of COVID-19 on Cancer Treatment for World Cancer Day
For World Cancer Day, Jeff Patton, MD, discusses COVID-19’s impact on cancer treatment and testing in an interview with Targeted Oncology.
OneOncology Creates Program to Enhance Clinical Trials at Participating Community Practices
OneOncology announced the creation of OneOncology Research Network, which is a national non-exclusive clinical trial site management organization.
2 Clarke Drive Cranbury, NJ 08512